Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Melanocytic naevi of other and unspecified parts of face based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 1007 | 698 | 309 |
Unadjusted prevalence (%) | 0.39 | 0.47 | 0.27 |
Mean age at first event (years) | 48.29 | 46.12 | 53.19 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.02 | 1.18 [0.64, 2.18] | 5.9e-1 | 49 |
15 years | 0.01 | 1.12 [0.59, 2.13] | 7.2e-1 | 40 |
5 years | 0.00 | 1.29 [0.58, 2.84] | 5.3e-1 | 12 |
1 year | - | - | - | - |
Index endpoint: CD2_BENIGN_MELANOCYTIC_FACE – Melanocytic naevi of other and unspecified parts of face
GWS hits: 0
before Melanocytic naevi of other and unspecified parts of face
after Melanocytic naevi of other and unspecified parts of face
Loading survival analyses plot
Loading survival analyses table